Category: Conference

Does this opioid naïve patient really need potent opioids? Think twice

Think Twice, exercise caution and generally avoid making assumptions about patient risk of subsequent prescription opioid use disorder, write authors of a recent editorial.

A worker in his 30’s had a “fall at work three weeks ago and has presented describing excruciating persistent back pain. An MRI scan of his spine has been normal. He has tried physiotherapy and non-steroidal anti-inflammatories for pain, but he reports persistent pain particularly when trying to work. (more…)

America could relax opioid treatment access policies

Canada and the United States (U.S.) face an opioid use disorder and opioid overdose epidemic.

The most effective OUD treatment is opioid agonist therapy (OAT). It means buprenorphine (with and without naloxone) and methadone. Although federal approval for OAT occurred decades ago, in both countries, access to and use of OAT is low. Restrictive policies and complex regulations contribute to limited treatment access. (more…)